SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-202540
Filing Date
2020-07-29
Accepted
2020-07-29 16:12:59
Documents
8
Period of Report
2020-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d61184d8k.htm 8-K 23034
2 EX-1.1 d61184dex11.htm EX-1.1 229179
3 EX-5.1 d61184dex51.htm EX-5.1 7511
4 EX-99.1 d61184dex991.htm EX-99.1 14072
5 EX-99.2 d61184dex992.htm EX-99.2 14152
6 GRAPHIC g61184g0729070045876.jpg GRAPHIC 3290
7 GRAPHIC g61184g0729070411610.jpg GRAPHIC 2477
8 GRAPHIC g61184g0729070748913.jpg GRAPHIC 2477
  Complete submission text file 0001193125-20-202540.txt   300987
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 201057430
SIC: 2836 Biological Products, (No Diagnostic Substances)